Joyce O'Shaugnessy, MD, Texas Oncology
Advertisement
Articles by Joyce O'Shaugnessy, MD, Texas Oncology
Advertisement
Latest Updated Articles
Prognostic Tools for Early-Stage HER2+ Breast CancerPublished: January 25th 2021 | Updated:
Current Treatment Landscape for HER2+ Breast CancerPublished: January 25th 2021 | Updated:
Updated Data for Metastatic HER2+ Breast CancerPublished: January 25th 2021 | Updated:
Advertisement
Advertisement
Trending on OncLive
1
Nonresponse to Bridging Therapy and Peak ALC After Cilta-Cel Are Associated With Neurotoxicity, NRM in Myeloma
2
FDA Underscores Risks Associated With DPD Deficiency and Capecitabine/5-FU Use in Cancer Care
3
Long-Term Cilta-Cel Data Show Low Rates of PFS Events in Standard-Risk R/R Myeloma
4
Orca-T With Reduced-Intensity Conditioning Yields Robust Efficacy in Hematologic Malignancies
5